Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by teaboy1on Jun 28, 2020 3:40pm

184 Views

Post# 31200784

RE:RE:RE:RE:Avacta?

I did read the Sona Nano site and can see why that using non toxic / non cancer causing rods in the human body would be advantageous but not why this would be an advantage on a lateral flow device?

From what I have researched gold nanorods are made by other companies... For example here - https://www.cd-bioparticles.com/product/basic-gold-nanorods-list-182.html?gclid=CjwKCAjw_-D3BRBIEiwAjVMy7ELQq8rEoDsOTMvRA8rcSxEZVYLKaz2eSHO8Keu22IbiOGGwPWQV5BoCFAkQAvD_BwE

So I guess it's the coating that makes Sona Nano unique?

Does anyone know if the nasal swab will have to be added to liquid before being applied to the lateral flow device?

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions